Skip to content

Asthma Link Effectiveness Trial

Asthma Link: A Partnership Between Pediatric Practices, Schools, and Families to Improve Medication Adherence and Health Outcomes in Children With Poorly Controlled Asthma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06388460
Enrollment
350
Registered
2024-04-29
Start date
2024-04-04
Completion date
2028-04-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Asthma

Keywords

asthma, childhood asthma, medication adherence, school-supervised asthma therapy, real-world

Brief summary

The goal of this cluster Randomized Control Trial is to determine the effectiveness of Asthma Link, a school supervised asthma therapy program, compared with an educational asthma workbook, in improving asthma symptoms for children with poorly controlled asthma aged 5-14.

Detailed description

Asthma is an extremely common chronic disease in childhood with significant morbidity. The majority of asthma morbidity in children is due to medication non-adherence, and both morbidity and medication non-adherence disproportionately impact minoritized children. School-supervised asthma therapy ensures that children receive their preventive asthma medication daily at school and has shown efficacy in improving medication adherence and asthma health outcomes, particularly in low-income and racial/ethnic minority children. However, this strategy has not been widely adopted in practice to produce meaningful public health impact. To address this gap, the study team developed a new model, Asthma Link, which partners pediatric practices, schools, and families to deliver school-supervised asthma therapy. This intervention leverages established infrastructure and requires minimal resources to operate, enhancing sustainability in a real-world setting. The pilot trial of Asthma Link showed improved asthma symptoms when compared to an enhanced usual care condition, particularly among low-income, Black and Latino children, and demonstrated trial feasibility. Moreover, the research team has rigorously adapted this intervention for real-world use using input from diverse, multi-level community stakeholders. This 14 site cluster randomized controlled trial will determine the effectiveness of Asthma Link versus an enhanced usual care condition in improving asthma health outcomes in school-aged children with poorly controlled asthma. The investigators central hypothesis is that children in Asthma Link will have higher Asthma Control Test scores at 6 months compared with children in enhanced usual care; with maintained improvements at 12 months. The secondary hypothesis is that children in Asthma Link will have higher inhaled corticosteroid adherence and quality of life scores, and lower rates of asthma exacerbations, school absences and parental lost workdays compared with children in the enhanced usual care condition.

Interventions

Providers enroll patients to receive school-supervised asthma therapy and an asthma educational workbook

OTHEREnhanced Usual Care

Providers enroll patients to receive an asthma educational workbook

Sponsors

University of Massachusetts, Worcester
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

STUDY INCLUSION/

Exclusion criteria

Child Inclusion Criteria: * Meet the eligibility criteria for Asthma Link (as described below) * Enrolled in Asthma Link (if randomized to the Asthma Link Condition) * Able and willing to provide informed assent Child

Design outcomes

Primary

MeasureTime frameDescription
Improving Asthma SymptomsBaseline, 6 months, 12 monthsAsthma Control Test to measure child's asthma control on a scale of 0-25. A score of 19 or less is considered poorly controlled asthma.

Secondary

MeasureTime frameDescription
Improving Medication AdherenceBaseline, 6 months, 12 monthsSurvey to measure medication adherence
Improving Healthcare UtilizationBaseline, 6 months, 12 monthsSurvey questions to measure # of emergency room visits, # of hospital admissions, # of oral steroid courses due to asthma
Reducing Parental Lost WorkdaysBaseline, 6 months, 12 monthsSurvey to measure the number of days a parent has missed work
Reducing School AbsencesBaseline, 6 months, 12 monthsSurvey to measure the number of days a child has missed school
Improving Quality of LifeBaseline, 6 months, 12 monthsSurvey to measure the quality of life of the child and parent

Countries

United States

Contacts

CONTACTMichelle Trivedi, MD
Michelle.Trivedi3@umassmed.edu7744418086
CONTACTMichelle Spano, MA
michelle.spano@umassmed.edu17746966875
PRINCIPAL_INVESTIGATORMichelle Trivedi, MD

UMass Chan Medical School

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026